U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 20:10:47 UTC 2023
Edited
by admin
on Sat Dec 16 20:10:47 UTC 2023
Protein Type VACCINE ANTIGEN
Protein Sub Type VIRAL ENVELOPE PROTEIN
Sequence Origin VIRAL
Sequence Type COMPLETE
Record UNII
RBJ7D8ZH4X
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Upalsecovatein
INN  
Official Name English
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron lineage B.1.1.529.5 also known as BA.5 (GISAID: EPI_ISL_12097410) spike (S) glycoprotein (S glycoprotein) (1-1255), stable prefusion conformation variant (R<sup>664</sup>>Q, R<sup>665</
Common Name English
upalsecovatein [INN]
Common Name English
Viral spike glycoprotein NVX-CoV2540 [664-glutamine,665-glutamine,667-glutamine,968-proline,969-proline] (severe acute respiratory syndrome coronavirus 2 variant B.1.1.529.5)
Common Name English
Code System Code Type Description
CAS
2918783-99-8
Created by admin on Sat Dec 16 20:10:47 UTC 2023 , Edited by admin on Sat Dec 16 20:10:47 UTC 2023
PRIMARY
FDA UNII
RBJ7D8ZH4X
Created by admin on Sat Dec 16 20:10:47 UTC 2023 , Edited by admin on Sat Dec 16 20:10:47 UTC 2023
PRIMARY
INN
13093
Created by admin on Sat Dec 16 20:10:47 UTC 2023 , Edited by admin on Sat Dec 16 20:10:47 UTC 2023
PRIMARY
From To
1_1064 1_1108
3_1064 3_1108
2_1064 2_1108
1_1014 1_1025
3_1014 3_1025
2_1014 2_1025
1_822 1_833
3_822 3_833
2_822 2_833
1_725 1_731
3_725 3_731
2_725 2_731
1_720 1_742
3_720 3_742
2_720 2_742
1_644 1_653
3_644 3_653
2_644 2_653
1_599 1_631
3_599 3_631
2_599 2_631
1_520 1_572
3_520 3_572
2_520 2_572
1_462 1_470
3_462 3_470
2_462 2_470
1_373 1_507
3_373 3_507
2_373 2_507
1_361 1_414
3_361 3_414
2_361 2_414
1_318 1_343
3_318 3_343
2_318 2_343
1_273 1_283
3_273 3_283
2_273 2_283
1_113 1_148
3_113 3_148
2_113 2_148
1_2 1_118
3_2 3_118
2_2 2_118
Glycosylation Link Type Site
N 1_44
N 1_56
N 1_104
N 1_131
N 1_147
N 1_216
N 1_264
N 1_313
N 1_325
N 1_585
N 1_598
N 1_639
N 1_691
N 1_699
N 1_733
N 1_1056
N 1_1080
N 1_1116
N 1_1140
N 1_1155
N 1_1176
N 2_44
N 2_56
N 2_104
N 2_131
N 2_147
N 2_216
N 2_264
N 2_313
N 2_325
N 2_585
N 2_598
N 2_639
N 2_691
N 2_699
N 2_733
N 2_1056
N 2_1080
N 2_1116
N 2_1140
N 2_1155
N 2_1176
N 3_44
N 3_56
N 3_104
N 3_131
N 3_147
N 3_216
N 3_264
N 3_313
N 3_325
N 3_585
N 3_598
N 3_639
N 3_691
N 3_699
N 3_733
N 3_1056
N 3_1080
N 3_1116
N 3_1140
N 3_1155
N 3_1176
Related Record Type Details
TARGET ORGANISM->VACCINE ANTIGEN
TARGET ORGANISM->VACCINE ANTIGEN
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL